Debevoise Advises Evercore and Guggenheim as Financial Advisors to Arena In Its Sale to Pfizer For a Total Equity Value of Approximately $6.7 Billion

14 December 2021

Debevoise & Plimpton LLP is advising Evercore Group LLC and Guggenheim Securities as financial advisors to Arena Pharmaceuticals (Nasdaq: ARNA) in its sale to Pfizer Inc. (NYSE: PFE). Under the terms of the agreement, Pfizer will acquire all the outstanding shares of Arena for $100 per share in an all-cash transaction for a total equity value of approximately $6.7 billion. For more information, please see the company’s press release.

Arena is a clinical stage company developing innovative potential therapies for the treatment of several immuno-inflammatory diseases.

The Debevoise team is led by M&A partner Andrew Bab and includes associate Caroline Brown.